On Friday 28 June, the European Commission announced the authorisation of the very first vaccine against the Chikungunya virus, a disease transmitted by infected mosquitoes.
The marketing of the “Ixchiq” vaccine, developed by an Austrian laboratory, was unanimously approved by the Member States of the European Union following an assessment by the European Medicines Agency (EMA).
“It is up to national authorities in each Member State to decide who will have access to the vaccine,...